Esteemed Recognitions, Quarterly Dividends, Production Commencements, and Interim Management Changes - Analyst Notes on Dow, Monsanto, Air Products, Mosaic and Huntsman

NEW YORK, June 18, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding The Dow Chemical Company (NYSE: DOW), Monsanto Company (NYSE: MON), Air Products & Chemicals, Inc. (NYSE: APD), Mosaic Co. (NYSE: MOS) and Huntsman Corporation (NYSE: HUN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/3838-100free.

--
The Dow Chemical Company Analyst Notes
On June 13, 2014, The Dow Chemical Company (Dow) announced that the American Chemical Society has awarded the 2015 Priestley Medal to its Director, Jacqueline K. Barton, recognizing her work on electron transport in DNA, her dedication to training young investigators, and her unwavering support for the chemistry enterprise. Congratulating Dr. Barton, Andrew N. Liveris, Chairman and CEO of Dow remarked, "Dr. Barton's research and discoveries of DNA properties have earned her a place among some of the nation's most brilliant scientific minds. She embodies the importance of imagination and innovation in her passion for science, and we are honored to have her as a member of our Board of Directors. On behalf of the 53,000 women and men of Dow, we congratulate Dr. Barton on this outstanding recognition." The full analyst notes on Dow are available to download free of charge at:

http://www.analystsreview.com/Jun-18-2014/DOW/report.pdf

--
Monsanto Company Analyst Notes
On June 6, 2014, the Board of Directors of Monsanto Company (Monsanto) declared a regular quarterly dividend of $0.43 per share on its common stock. The Company's shareholders of record on July 3, 2014, will be paid the aforesaid dividends on July 25, 2014. Pierre Courduroux, Monsanto's CFO remarked, "Quarterly dividends are an important component of Monsanto's strategy in returning value to our shareowners. We will continue to use our cash position to generate shareholder value through dividends as well as share repurchases and strategic investments in our business." Monsanto also announced that it will release it Q3 FY 2014 earnings on June 25, 2014. The full analyst notes on Monsanto are available to download free of charge at:

http://www.analystsreview.com/Jun-18-2014/MON/report.pdf

--
Air Products & Chemicals, Inc. Analyst Notes
On June 11, 2014, Air Products & Chemicals, Inc. (Air Products), together with Matheson Tri-Gas, Inc. (MATHESON) announced the commencement of production operations in its jointly-owned Big Piney helium facility, with the filling and shipping of the first two 11,000 gallon helium ISO containers from the facility. Designed to produce 200 million standard cubic feet of helium per year initially, the plant is expected to expand to 400 million standard cubic feet per year in the future. The facility purifies and liquefies a helium feedgas stream that is supplied by Denbury Resources' Riley Ridge gas processing plant. The Denbury plant processes a raw gas stream produced from the LaBarge Field in Wyoming, one of the largest helium-rich gas fields in the United States. Walter Nelson, General Manager - Worldwide Helium at Air Products commented, "This plant is beginning production operations at a good time as both suppliers and manufacturing end-users of helium are still recovering from a global helium supply shortage. Big Piney alone won't solve the supply issue, but it will help to provide additional helium at this critical time. Going forward, the Big Piney plant will further diversify our helium source portfolio in our efforts to reliably serve our customers." The full analyst notes on Air Products are available to download free of charge at:

http://www.analystsreview.com/Jun-18-2014/APD/report.pdf

--
Mosaic Co. Analyst Notes
On May 29, 2014, the Board of Directors of Mosaic Co. (Mosaic) announced that it has named Lawrence W. Stranghoener as Interim CEO, effective June 1, 2014, as its current President and CEO James T. Prokopanko's is taking an anticipated medical leave of absence for surgery to treat his previously disclosed ailment. "It is in Mosaic's best interest, and mine, that I focus on my health during the six- to eight-week period that my doctors tell me I should expect to be out of the office for surgery and recovery," remarked Prokopanko. "This surgery has been part of the original plan laid out by my medical team and I am eager to take this next important step in my treatment. Larry is an outstanding leader who enjoys the deep respect of our employees and other stakeholders. I will make myself available to him and the rest of our management team, as needed, during my leave. I am looking forward to actively re-engaging in the day-to-day activities of the business once I have recovered from surgery." The full analyst notes on Mosaic are available to download free of charge at:

http://www.analystsreview.com/Jun-18-2014/MOS/report.pdf

--
Huntsman Corporation Analyst Notes
On June 13, 2014, Huntsman Corporation's (Huntsman) stock closed at $28.09, reflecting a 0.68% increase over its previous day's closing price. Over the past 3-months, Huntsman's stock has climbed 21.39%, significantly outperforming the S&P 500 which has gained 4.86% during that same period. The full analyst notes on Huntsman are available to download free of charge at:

http://www.analystsreview.com/Jun-18-2014/HUN/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review